Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605656 · ClinicalTrials.gov registry record
A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 188
- Enrollment target
NCT01605656: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01605656 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 188 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01605656 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
Study Summary
The goal of this study is to better understand the factors that might prevent HIV-positive women from having routine pap smear screenings. Researchers also want to learn what might make it easier or encourage women to have these screenings.
Primary Outcome
Participants rank Nominal Group Technique (NGT) items (cervical cancer screening barriers and strategies to improve screening) from 1-5 (1-least important: 5-most important). Once two coders have calculated rankings, the 5 items receiving the highest number of points will be deemed the 5 barriers to cervical cancer screening. Similarly, the 5 strategy-based items receiving highest number of points will be deemed essential strategies to improving cervical cancer screening at Thomas Street Health
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Cognitive Interview
- BEHAVIORAL Focus Groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-04 |
What the finished NCT01605656 record still lists
NCT01605656 is an observational study that tracks outcomes without assigning an intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT01605656 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01605656 about?
NCT01605656 is a clinical study titled "A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women". The goal of this study is to better understand the factors that might prevent HIV-positive women from having routine pap smear screenings. Researchers also want to learn what might make it easier or encourage women to have these screenings.
What is the current status of trial NCT01605656?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2012-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01605656?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Cognitive Interview (BEHAVIORAL), Focus Groups (BEHAVIORAL).
Who is sponsoring clinical trial NCT01605656?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia